Cellular mechanisms in activation of Na-K-Cl cotransport in nasal gland acinar cells of guinea pigs

J Membr Biol. 1995 Aug;146(3):307-14. doi: 10.1007/BF00233950.

Abstract

The cellular regulation mechanism of Na-K-Cl cotransport was studied in dispersed acinar cells of the guinea pig nasal gland by a microfluorimetric imaging method using the Na(+)-sensitive dye sodium-binding benzofuran isophthalate. Addition of 1 micron acetylcholine (ACh) induced an immediate increase in intracellular Na+ concentration ([Na+]i) by 36.7 +/- 9.9 mM, which was almost completely abolished by the addition of atropine. The increased [Na+]i after cholinergic stimulation was due to the external (Cl-)-dependent cotransport system (about 80% of the total Na+ influx) and the dimethyl amiloride-sensitive (Na+)-H+ exchange system (of about 20%). The ACh-induced increase in [Na+]i was dependent on extracellular Ca2+ and was prevented by pretreatment with 8-(N, N-diethylamino)octyl-3,4,5-trimethoxybenzoate or O-O'-bis(2-aminophenyl)ethyleneglycol-N, N, N', N'-tetraacetic acid tetraacetoxymethylester. Addition of 1 microns ionomycin mimicked the ACh-induced increase in [Na+]i which was dependent on external Cl-. Moreover, both a calmodulin antagonist trifluoperazine and a myosin light chain kinase inhibitor ML-7 reduced the ACh-induced response in [Na+]i. However, the following treatment did not affect the basal [Na+]i nor the ACh-induced increase in [Na+]i: (i) addition of dibutyryl cAMP, 8-Br-cGMP, or phorbol 12-myristate 13-acetate, (ii) pretreatment of protein kinase inhibitors, H-89, H-8, H-7 or chelerythrine, (iii) prevention of cytosolic Cl- efflux by the addition of diphenylamine-2-carboxylic acid or, (iv) prevention of cytosolic K+ efflux by the addition of charybdotoxin.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Alkaloids
  • Animals
  • Benzophenanthridines
  • Biological Transport / drug effects
  • Bucladesine / pharmacology
  • Bumetanide / pharmacology
  • Calcium / physiology
  • Calmodulin / antagonists & inhibitors
  • Calmodulin / physiology
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / metabolism*
  • Charybdotoxin / pharmacology
  • Cholinergic Fibers / physiology*
  • Cyclic AMP / pharmacology
  • Cyclic AMP / physiology
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Cyclic GMP / physiology
  • Enzyme Inhibitors / pharmacology
  • Exocrine Glands / drug effects
  • Exocrine Glands / innervation
  • Exocrine Glands / metabolism*
  • Furosemide / pharmacology
  • Guinea Pigs
  • Ionomycin / pharmacology
  • Ionophores / pharmacology
  • Isoquinolines / pharmacology
  • Nasal Cavity*
  • Phenanthridines / pharmacology
  • Protein Kinase Inhibitors
  • Protein Kinases / physiology
  • Second Messenger Systems
  • Signal Transduction / drug effects*
  • Sodium / metabolism*
  • Sodium-Potassium-Chloride Symporters
  • Sulfonamides*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Trifluoperazine / pharmacology
  • Vasoactive Intestinal Peptide / pharmacology

Substances

  • Alkaloids
  • Benzophenanthridines
  • Calmodulin
  • Carrier Proteins
  • Enzyme Inhibitors
  • Ionophores
  • Isoquinolines
  • Phenanthridines
  • Protein Kinase Inhibitors
  • Sodium-Potassium-Chloride Symporters
  • Sulfonamides
  • Bumetanide
  • Charybdotoxin
  • Trifluoperazine
  • 8-bromocyclic GMP
  • Vasoactive Intestinal Peptide
  • Ionomycin
  • Bucladesine
  • Furosemide
  • Sodium
  • Cyclic AMP
  • chelerythrine
  • Protein Kinases
  • Cyclic GMP
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • Acetylcholine
  • Tetradecanoylphorbol Acetate
  • Calcium